Novel active substance launches vs Sales growth at constant exchange rates

Novel active substance launches and Sales growth at constant exchange rates worldwide, compared over time.

Change the pair

Compare different indicators

The series

Over time

Global, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

Novel active substance launches

Unit: count · 2 observations

Line chart
Novel active substance launchesNovel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025). 0 200 400 600 800 1,000 2004 2008 2012 2016 2020 2024 942 79
Novel active substance launchesNovel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025). 0 300 600 900 1,200 2004 2008 2012 2016 2020 2024 942 79
Novel active substance launchesNovel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025). 0 300 600 900 1,200 2004 2008 2012 2016 2020 2024 942 79
View the underlying data
Novel active substance launches
Period Type Value
2004–2023 Actual 942
2025 Actual 79
Source: IFPMA, IQVIA · CC BY 4.0 · Full series

Sales growth at constant exchange rates

Unit: % · 2 observations

Line chart
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 2004 2008 2012 2016 2020 2024 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 2004 2008 2012 2016 2020 2024 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 2004 2008 2012 2016 2020 2024 3% 18%
View the underlying data
Sales growth at constant exchange rates
Period Type Value
Q1 2026 Actual 3%
Q2 2026 Actual 17.8%
Source: Roche, Sanofi · CC BY 4.0 · Full series

Provenance

Where these numbers come from

Novel active substance launches

Total number of novel active substances launched.

2 observations in Global · source organisations: IFPMA, IQVIA

Sales growth at constant exchange rates

Percentage change in sales calculated at constant exchange rates over the specified period.

2 observations in Global · source organisations: Roche, Sanofi

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related